| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And Chief Executive
2 companies
Curran Terrie is a President And Chief Executive at Phathom Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 9 sells.
Estimated insider holdings value: $4.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | PHAT Phathom Pharmaceuticals, Inc. | President And Chief Executive | Sell | 19,109 | $6.59 | $125,884.36 | -5.0% | -42.6% | +100.4% | |
| Nov 11, 2024 | ARQT Arcutis Biotherapeutics, Inc. | Director | Sell | 8,687 | $10.85 | $94,238.31 | -46.1% | +6.9% | +121.7% | |
| Jul 15, 2024 | PHAT Phathom Pharmaceuticals, Inc. | President And Chief Executive | Sell | 33,848 | $11.72 | $396,698.56 | -8.2% | +20.6% | -32.6% | |
| Mar 22, 2024 | PHAT Phathom Pharmaceuticals, Inc. | President And Chief Executive | Sell | 16,851 | $9.11 | $153,512.61 | -3.9% | +7.2% | -43.5% | |
| Apr 6, 2023 | PHAT Phathom Pharmaceuticals, Inc. | President And Chief Executive | Buy | 12,919 | $7.82 | $101,025.29 | +7.4% | +77.7% | +43.2% | |
| Mar 1, 2023 | PHAT Phathom Pharmaceuticals, Inc. | President And Chief Executive | Sell | 1,436 | $8.54 | $12,265.02 | -0.8% | +26.5% | +18.8% | |
| Jan 20, 2023 | PHAT Phathom Pharmaceuticals, Inc. | President And Chief Executive | Sell | 5,821 | $8.20 | $47,729.29 | -3.2% | +20.1% | -13.0% | |
| Nov 21, 2022 | PHAT Phathom Pharmaceuticals, Inc. | President And Chief Executive | Sell | 1,526 | $9.60 | $14,649.60 | -1.8% | -2.9% | -26.0% | |
| May 13, 2022 | PHAT Phathom Pharmaceuticals, Inc. | President And Chief Executive | Buy | 20,500 | $7.41 | $151,835.30 | +46.5% | +14.4% | +68.5% | |
| Mar 22, 2021 | PHAT Phathom Pharmaceuticals, Inc. | President And Chief Executive | Sale+OE | 11,513 | $43.32 | $498,750.86 | -91.0% | -18.9% | -66.2% |